Keywords: gp120, enter, phase, ii, trials, genentech, biocine

GP120 TO ENTER PHASE II TRIALS

Article | 21 December 1992

Print This

Genentech's and Biocine's GP120 AIDS vaccines are to enter Phase II trials sponsored by the National Institute of Allergy and ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in